Wilson Sonsini Goodrich & Rosati is advising DTx Pharma on the transaction. A preclinical-stage biotechnology company, DTx Pharma announced that it has been acquired by Novartis. In addition...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here